Ruth Elizabeth Langley

机构：MRC Clinical Trials Unit at UCL, University College London · ORCID：0000-0002-9706-016X

发表论文 197 篇 · 总被引 16875 次 · h-index 44

代表论文

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial (2022 · PLoS Medicine · 被引 125)
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol (2023 · The Lancet Oncology · 被引 116)
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial (2023 · British Journal of Cancer · 被引 33)
Cardiovascular health: an important component of cancer survivorship (2023 · BMJ Oncology · 被引 28)
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial (2022 · JNCI Cancer Spectrum · 被引 25)
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol (2025 · The Lancet Oncology · 被引 24)